Literature DB >> 8611567

Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.

P Foran1, G W Lawrence, C C Shone, K A Foster, J O Dolly.   

Abstract

The seven types (A--G) of botulinum neurotoxin (BoNT) are Zn2+ -dependent endoproteases that potently block neurosecretion. Syntaxin is presently thought to be the sole substrate for BoNT/C1, and synaptosomal-associated protein of Mr = 25 000 (SNAP-25) is selectively proteolyzed by types A and E. In this study, the effects of C1 on Ca2+ -regulated exocytosis of dense core granules from adreno-chromaffin cells were examined together with its underlying molecular action. Intact chromaffin cells were exposed to the toxin, and catecholamine release therefrom was then measured in conjunction with the monitoring of syntaxin cleavage by Western blotting. A good correlation was obtained between degradation of syntaxin 1A/B and reduction in Ca2+- or Ba2+-dependent secretion. However, blotting with antibodies against a C-terminal peptide of SNAP-25 revealed the additional disappearance of immunoreactivity, with the same toxin concentration dependency as syntaxin breakdown. Notably, the cleaved SNAP-25 product was similar in size to that produced by BoNT/A; however, contamination of BoNT/C1 by serotypes A or E was eliminated. Therefore, it is concluded that syntaxin 1A/B and SNAP-25 are cleaved in intact cells poisoned with only C1. Notably, C1 treatment of chromaffin cells abolished Ca2+ -evoked secretion following digitonin permeabilization, compared with partial inhibition by BoNT/A, suggesting the importance of syntaxin for catecholamine release. Unexpectedly, C1 failed to proteolyze a soluble recombinant SNAP-25, even though it served as an efficient substrate for BoNT/A. These interesting observations suggest that C1 can only efficiently cleave SNAP-25 in intact cells, possibly due to the existence therein of a unique conformation and/or the participation of accessory factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611567     DOI: 10.1021/bi9519009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  63 in total

1.  Syntaxin is required for cell division.

Authors:  S D Conner; G M Wessel
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

2.  Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay.

Authors:  M Wictome; K Newton; K Jameson; B Hallis; P Dunnigan; E Mackay; S Clarke; R Taylor; J Gaze; K Foster; C Shone
Journal:  Appl Environ Microbiol       Date:  1999-09       Impact factor: 4.792

3.  Syntaxin modulation of calcium channels in cortical synaptosomes as revealed by botulinum toxin C1.

Authors:  J B Bergsman; R W Tsien
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

4.  [Pharmacology of botulinum toxin drugs].

Authors:  D Dressler
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

5.  Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism.

Authors:  Callista B Harper; Sally Martin; Tam H Nguyen; Shari J Daniels; Nickolas A Lavidis; Michel R Popoff; Gordana Hadzic; Anna Mariana; Ngoc Chau; Adam McCluskey; Phillip J Robinson; Frederic A Meunier
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

6.  Mass Spectrometric Identification and Differentiation of Botulinum Neurotoxins through Toxin Proteomics.

Authors:  Suzanne R Kalb; John R Barr
Journal:  Rev Anal Chem       Date:  2013-08       Impact factor: 3.067

Review 7.  [Pharmacological aspects of therapeutic botulinum toxin preparations].

Authors:  D Dressler
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

8.  Identification of a Botulinum Neurotoxin-like Toxin in a Commensal Strain of Enterococcus faecium.

Authors:  Sicai Zhang; Francois Lebreton; Michael J Mansfield; Shin-Ichiro Miyashita; Jie Zhang; Julia A Schwartzman; Liang Tao; Geoffrey Masuyer; Markel Martínez-Carranza; Pål Stenmark; Michael S Gilmore; Andrew C Doxey; Min Dong
Journal:  Cell Host Microbe       Date:  2018-01-27       Impact factor: 21.023

9.  Enhanced detection of type C botulinum neurotoxin by the Endopep-MS assay through optimization of peptide substrates.

Authors:  Dongxia Wang; Joan Krilich; Jakub Baudys; John R Barr; Suzanne R Kalb
Journal:  Bioorg Med Chem       Date:  2015-04-10       Impact factor: 3.641

10.  Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.

Authors:  Dongxia Wang; Joan Krilich; Sabine Pellett; Jakub Baudys; William H Tepp; John R Barr; Eric A Johnson; Suzanne R Kalb
Journal:  Biochim Biophys Acta       Date:  2013-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.